AstraZeneca COPD drug tozorakimab shows positive late-stage trial results

AstraZeneca on Tuesday released full results from two successful late-stage trials on its experimental drug for chronic obstructive pulmonary disease, boosting hopes that it could generate multibillion-dollar sales for the company.  The biologic medicine, tozorakimab, is under priority review by the Food and Drug Administration, with U.S. approval expected in the first quarter of 2027….

Read Full News

Novartis trial failure raises stakes for Amgen and Eli Lilly in Lp(a) drug race

Blood sample for a lipoprotein(a) test. Md Babul Hosen | Istock | Getty Images Novartis‘ failure in a closely watched cardiovascular trial has raised questions about one of the pharmaceutical industry’s biggest drug races and rival treatments from U.S. heavyweights Amgen and Eli Lilly. The pelacarsen drug, developed jointly with Ionis Pharmaceuticals, reduced a particularly…

Read Full News

JLR to cut thousands of jobs in cost-saving drive

General view of Land Rover cars outside the Jaguar Land Rover factory on April 7, 2025 in Halewood, England. Richard Martin-roberts | Getty Images News | Getty Images Thousands of workers at Britain’s Jaguar Land Rover (JLR) will be offered voluntary redundancies as the luxury car manufacturer responds to intense competition from cheaper Chinese rivals,…

Read Full News